diabetes mellitus, type 2
Showing NaN - NaN of 139
Diabetes, Type 2, Obesity, Prediabetic State Trial in Toronto (Early (7:00 - 16:00) TRE, Mid (9:30 - 18:30) TRE, Late (12:00 -
Not yet recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Early (7:00 - 16:00) TRE
- +2 more
-
Toronto, Ontario, CanadaRemote Ontario-wide
Oct 31, 2023
Obesity, Diabetes, Type 2 Trial in Toronto (Dairy and plant-based dairy beverages and solids)
Completed
- Obesity
- Diabetes Mellitus, Type 2
- Dairy and plant-based dairy beverages and solids
-
Toronto, Ontario, CanadaDepartment of Nutritional Sciences, C. David Naylor Building
Jun 22, 2023
Diabetes, Type 2, Obesity Trial in Toronto (Time restricted feeding, Standard lifestyle)
Recruiting
- Diabetes Mellitus, Type 2
- Obesity
- Time restricted feeding
- Standard lifestyle
-
Toronto, Ontario, CanadaLeadership Sinai Centre foe Diabetes - Mount Sinai Hospital
Jan 30, 2023
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Tuscumbia, Alabama
- +393 more
Jan 17, 2023
Diabetes, Type 2, Chronic Kidney Disease Trial in Worldwide (Semaglutide, Placebo (Semaglutide))
Recruiting
- Diabetes Mellitus, Type 2
- Chronic Kidney Disease
- Semaglutide
- Placebo (Semaglutide)
-
Tucson, Arizona
- +33 more
Jan 17, 2023
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +3 more
-
Guntersville, Alabama
- +91 more
Nov 11, 2022
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +3 more
-
Birmingham, Alabama
- +178 more
Nov 3, 2022
Diabetes, Type 2, Overweight Trial in Toronto (Sleeve Gastrectomy AND Pancreas after Kidney Transplantation (Staggered
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Overweight
- Sleeve Gastrectomy AND Pancreas after Kidney Transplantation (Staggered Approach)
- Combined Sleeve Gastrectomy and Pancreas transplantation
-
Toronto, Ontario, CanadaToronto General Hospital
Oct 20, 2022
Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Linagliptin
- +2 more
-
Phoenix, Arizona
- +82 more
Aug 23, 2022
Cancer, Breast, Cancer, Ovarian, Cancer, Colorectal Trial in Toronto (FHAMe Intervention)
Active, not recruiting
- Cancer, Breast
- +6 more
- FHAMe Intervention
-
Toronto, Ontario, CanadaMount Sinai Hospital
Aug 10, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Little Rock, Arkansas
- +228 more
Jul 11, 2022
Diabetes, Type 2 Trial in Worldwide (IcoSema, Semaglutide 1 mg)
Recruiting
- Diabetes Mellitus, Type 2
- IcoSema
- Semaglutide 1 mg
-
Birmingham, Alabama
- +81 more
Jun 28, 2022
Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Metformin DR
- +3 more
-
Glendale, Arizona
- +86 more
Jun 7, 2022
In-utero Exposure to Metformin in 5-11 Year Old Offspring of
Recruiting
- Diabetes Mellitus, Type 2
- +3 more
-
Toronto, Ontario, CanadaMount Sinai Hospital
May 12, 2022
Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Oral semaglutide
-
Buena Park, California
- +177 more
Mar 31, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Montgomery, Alabama
- +444 more
Mar 11, 2022
Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))
Terminated
- Diabetes Mellitus, Type 2
- 4 mm x 32G pen needle (Nano)
- 8mm x 31G pen needle (Short)
-
Minneapolis, Minnesota
- +2 more
Feb 28, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Completed
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +128 more
Feb 14, 2022
Diabetes, Type 2, Glucose Trial in Canada (FreeStyle Libre Flash Glucose Monitor, Diabetes self-management education)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Glucose
- FreeStyle Libre Flash Glucose Monitor
- Diabetes self-management education
-
Brampton, Ontario, Canada
- +5 more
Feb 4, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Anniston, Alabama
- +228 more
Jan 6, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +3 more
-
Concord, California
- +166 more
Jan 6, 2022
Diabetes, Type 2, Impaired Renal Function Trial in Toronto (Dapagliflozin 10 MG [Farxiga])
Unknown status
- Diabetes Mellitus, Type 2
- Impaired Renal Function
- Dapagliflozin 10 MG [Farxiga]
-
Toronto, Ontario, CanadaDavid Cherney, CM, PhD
Sep 7, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Andalusia, Alabama
- +71 more
Jul 1, 2021
Diabetes, Type 2 Trial in Canada, United States (CGM, SMBG)
Completed
- Diabetes Mellitus, Type 2
- CGM
- SMBG
-
Huntington Beach, California
- +9 more
Mar 18, 2021
Diabetic Complications of Foot in A Large Canadian Population
Completed
- Diabetes Mellitus, Type 2
- +7 more
-
Toronto, CanadaLMC Healthcare
Feb 24, 2021